P2B-091

Municipal institution "Chernivtsi Regional Clinical Oncologic Dispensary" (Chernivtsi, Ukraine) › P2B-091

P2B-091

A Multicenter, Randomized, Open-Label Phase 2b Study to Investigate the Preliminary Efficacy and Safety of INNO-206 (Doxorubicin-EMCH) Compared to Doxorubicin in Subjects With Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma · Phase II
Municipal institution "Chernivtsi Regional Clinical Oncologic Dispensary" (Chernivtsi, Ukraine) · Dr. Ito
consented 2013-03-21

completed

AEs

4

Serious

0

Dropout signal

–

Adverse events

4

Grade 2 pyrexia with onset in cycle 6 (2013-08-01); assessed as not related to study drug (not related); resolved 2013-08-03.

moderate assessed

Grade 1 nausea with onset in cycle 6 (2013-07-21); assessed as not related to study drug (not related); resolved 2013-07-26.

mild assessed

Grade 2 alopecia with onset in cycle 4 (2013-06-24); assessed as related to study drug (probable); not resolved at last follow-up.

moderate assessed

Grade 1 asthenia with onset in cycle 4 (2013-06-19); assessed as not related to study drug (not related); resolved 2013-07-11.

mild assessed

Data queries

0

No data queries. Open queries would appear here for this patient.